---
title: "Mizuho Securities Sticks to Its Buy Rating for MBX Biosciences, Inc. (MBX)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294120984.md"
description: "Mizuho Securities analyst Uy Ear reiterated a Buy rating on MBX Biosciences (MBX) with a $91.00 price target. This follows UBS's July 24 report, which also maintained a Buy rating and set a $90.00 target for the healthcare stock."
datetime: "2026-07-28T22:35:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294120984.md)
  - [en](https://longbridge.com/en/news/294120984.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294120984.md)
generator: "portal-rs"
---

# Mizuho Securities Sticks to Its Buy Rating for MBX Biosciences, Inc. (MBX)

Mizuho Securities analyst Uy Ear reiterated a Buy rating on MBX Biosciences, Inc. today and set a price target of $91.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Ear covers the Healthcare sector, focusing on stocks such as Alkermes, Evolus, and Arcutis Biotherapeutics. According to TipRanks, Ear has an average return of 6.1% and a 43.00% success rate on recommended stocks. 

In a report released on July 24, UBS also reiterated a Buy rating on the stock with a $90.00 price target.

### Related Stocks

- [MBX.US](https://longbridge.com/en/quote/MBX.US.md)
- [MFG.US](https://longbridge.com/en/quote/MFG.US.md)
- [8411.JP](https://longbridge.com/en/quote/8411.JP.md)
- [ALKS.US](https://longbridge.com/en/quote/ALKS.US.md)
- [EOLS.US](https://longbridge.com/en/quote/EOLS.US.md)
- [ARQT.US](https://longbridge.com/en/quote/ARQT.US.md)
- [UBS.US](https://longbridge.com/en/quote/UBS.US.md)

## Related News & Research

- [Bank of New York Mellon Corp Purchases Shares of 88,927 MBX Biosciences, Inc. $MBX](https://longbridge.com/en/news/298099359.md)
- [Legal & General Group Plc Makes New $1.19 Million Investment in MBX Biosciences, Inc. $MBX](https://longbridge.com/en/news/298278869.md)
- [Braveheart Bio, Inc. reports Q2 results](https://longbridge.com/en/news/298361396.md)
- [Climb Bio executives to speak at Wells Fargo healthcare conference fireside chat](https://longbridge.com/en/news/297773910.md)
- [How Investors May Respond To Evercore (EVR) Hiring Senior EMEA Healthcare Banker John Pissanos](https://longbridge.com/en/news/298090119.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**